These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26940609)

  • 1. New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.
    Bhushan A; Martucci NJ; Usta OB; Yarmush ML
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):475-7. PubMed ID: 26940609
    [No Abstract]   [Full Text] [Related]  

  • 2. Troubleshooting computational methods in drug discovery.
    Kortagere S; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development.
    Ball SE; Scatina JA; Sisenwine SF; Fisher GL
    Drug Chem Toxicol; 1995 Feb; 18(1):1-28. PubMed ID: 7768197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of drug metabolites.
    Izumi T
    Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
    [No Abstract]   [Full Text] [Related]  

  • 5. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.
    Luker T; Alcaraz L; Chohan KK; Blomberg N; Brown DS; Butlin RJ; Elebring T; Griffin AM; Guile S; St-Gallay S; Swahn BM; Swallow S; Waring MJ; Wenlock MC; Leeson PD
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5673-9. PubMed ID: 21852131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current drug metabolism.
    Kerns EH
    Curr Drug Metab; 2008 Nov; 9(9):845-6. PubMed ID: 18991579
    [No Abstract]   [Full Text] [Related]  

  • 8. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of drug metabolism and toxicity: systems biology approach and modeling.
    Bugrim A; Nikolskaya T; Nikolsky Y
    Drug Discov Today; 2004 Feb; 9(3):127-35. PubMed ID: 14960390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on incidence and nature of testicular toxicity findings in pharmaceutical development survey: a pathologist's perspective.
    Creasy DM
    Birth Defects Res B Dev Reprod Toxicol; 2011 Dec; 92(6):508-10. PubMed ID: 21818841
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro screening of drug metabolism during drug development: can we trust the predictions?
    Pelkonen O; Raunio H
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):49-59. PubMed ID: 16922652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism.
    Tuschl G; Lauer B; Mueller SO
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):855-70. PubMed ID: 18624675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery.
    Prakash C; Sharma R; Gleave M; Nedderman A
    Curr Drug Metab; 2008 Nov; 9(9):952-64. PubMed ID: 18991592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose toxicity and repeated dose toxicity studies: introductory remarks.
    Kurokawa Y; Matsuzawa T
    J Toxicol Sci; 1996 Dec; 21(5):413-6. PubMed ID: 9035047
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity.
    Van Summeren A; Renes J; van Delft JH; Kleinjans JC; Mariman EC
    Toxicol In Vitro; 2012 Apr; 26(3):373-85. PubMed ID: 22274661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging technologies for the study of drug metabolism and pharmacokinetics.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):141-2. PubMed ID: 20843297
    [No Abstract]   [Full Text] [Related]  

  • 18. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluations of organ system development in juvenile toxicology testing.
    Robinson K
    Reprod Toxicol; 2008 Sep; 26(1):51-3. PubMed ID: 18595655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 21st century drug development: advances, opportunities and challenges.
    Bhogal N
    Altern Lab Anim; 2009 Sep; 37(4):335-9. PubMed ID: 19807207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.